Cassava Sciences Inc vs Live Nation Entertainment, Inc. — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Live Nation Entertainment, Inc. trades at $183.14 (market cap $42.71B). The key difference: Live Nation Entertainment, Inc. is far larger — about 894.5× Cassava Sciences Inc's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | LYV | |
|---|---|---|
Market Cap | $47.75M | $42.71B |
Sector | Health | Industrials |
52-Week High | $4.64 | $186.59 |
52-Week Low | $0.87 | $125.61 |
Enterprise Value | -$34.93M | $44.92B |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →